Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
暂无分享,去创建一个
H. Aburatani | Y. Lio | K. K. Pandey | M. Jaggi | S. Chauhan | M. Bell | A. Watanabe | M. D. Koch | N. Vinayek | M. Ebeling | Kelley Vannatta
[1] Y. Lio,et al. Combined Staining of TAG-72, MUC1, and CA125 Improves Labeling Sensitivity in Ovarian Cancer , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] M. Copin,et al. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms , 2007, Oncogene.
[3] Lynette M. Smith,et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) , 2006, Modern Pathology.
[4] B. Leggett,et al. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. , 2006, Human pathology.
[5] A. Jemal,et al. Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.
[6] H. Aburatani,et al. Overexpression of MUC13 is associated with intestinal‐type gastric cancer , 2005, Cancer science.
[7] C. J. Barnes,et al. p21-Activated Kinase 1 Regulates Microtubule Dynamics by Phosphorylating Tubulin Cofactor B , 2005, Molecular and Cellular Biology.
[8] P. Rao,et al. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. , 2005, Cancer research.
[9] L. Packer,et al. Expression of the cell surface mucin gene family in adenocarcinomas. , 2004, International journal of oncology.
[10] J. Meza,et al. Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis , 2004, Cancer Research.
[11] K. Carraway,et al. Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis. , 2002, The Biochemical journal.
[12] T. Stossel,et al. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1 , 2002, Nature Cell Biology.
[13] R. Ozols. Update on the management of ovarian cancer. , 2002, Cancer journal.
[14] U. Menon. Ovarian cancer screening , 2002, Canadian Medical Association Journal.
[15] J. Feldner,et al. Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization. , 2002, Experimental cell research.
[16] H. Friess,et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Batra,et al. Structural organization and classification of the human mucin genes. , 2001, Frontiers in bioscience : a journal and virtual library.
[19] G. Sutherland,et al. MUC13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells* , 2001, The Journal of Biological Chemistry.
[20] M. Hollingsworth,et al. Identification of MUC1 proteolytic cleavage sites in vivo. , 2001, Biochemical and biophysical research communications.
[21] M. Hung,et al. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies , 2000, Oncogene.
[22] H. Ji,et al. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines , 2000, Oncogene.
[23] R. Dodge,et al. Mucin gene expression in ovarian cancers. , 1998, Cancer research.
[24] J. Mendelsohn,et al. Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.
[25] S. Mok,et al. The biology of ovarian cancer. , 1998, Seminars in oncology.
[26] N. Kohno,et al. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. , 1998, Cancer research.
[27] C. A. Carraway,et al. Reversible Disruption of Cell-Matrix and Cell-Cell Interactions by Overexpression of Sialomucin Complex* , 1997, The Journal of Biological Chemistry.
[28] M. Cummings,et al. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours , 1997, The Journal of pathology.
[29] M. Nieman,et al. Cadherins Promote Skeletal Muscle Differentiation in Three-dimensional Cultures , 1997, The Journal of cell biology.
[30] J. Wesseling,et al. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.
[31] C. Balagué,et al. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. , 1995, Gastroenterology.
[32] A. Sonnenberg,et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.
[33] G. Edelman,et al. Topology of cell adhesion molecules. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[35] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[36] S. Gendler,et al. Epithelial mucin genes. , 1995, Annual review of physiology.
[37] N. Dubrawsky. Cancer statistics , 2022 .